Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

**Background:** This study evaluated the clinical outcomes and economic results of transdermal oxybutynin compared to fesoterodine, tolterodine, solifenacin, oxybutynin, trospium chloride, and mirabegron for overactive bladder syndrome in Spain. **Materials and Methods:** A Markov model was built w...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Crespo, Pedro Blasco, Marcelo Guigini, Jordi Galván
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2018-01-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9811
Tags: Add Tag
No Tags, Be the first to tag this record!